LncRNA FENDRR inhibited MDR1 expression via interacting with HuR and miR-184 and thereby attenuates adriamycin resistance in CML cells [11]. Here, ELAVL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.